Intravenous Autologous Bone Marrow Mononuclear Cell Transplantation for Stroke: Phase1/2a Clinical Trial in a Homogeneous Group of Stroke Patients

The goal of this clinical trial was to assess the feasibility and safety of transplanting autologous bone marrow mononuclear cells into patients suffering severe embolic stroke. Major inclusion criteria included patients with cerebral embolism, age 20–75 years, National Institute of Health Stroke Sc...

Descripción completa

Detalles Bibliográficos
Autores principales: Taguchi, Akihiko, Sakai, Chiaki, Soma, Toshihiro, Kasahara, Yukiko, Stern, David M., Kajimoto, Katsufumi, Ihara, Masafumi, Daimon, Takashi, Yamahara, Kenichi, Doi, Kaori, Kohara, Nobuo, Nishimura, Hiroyuki, Matsuyama, Tomohiro, Naritomi, Hiroaki, Sakai, Nobuyuki, Nagatsuka, Kazuyuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc. 2015
Materias:
Clinical Trials
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4582686/
https://www.ncbi.nlm.nih.gov/pubmed/26176265
http://dx.doi.org/10.1089/scd.2015.0160

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4582686/
https://www.ncbi.nlm.nih.gov/pubmed/26176265
http://dx.doi.org/10.1089/scd.2015.0160

Ejemplares similares